4.6 Article

Delivery Mode and the Transition of Pioneering Gut-Microbiota Structure, Composition and Predicted Metabolic Function

Journal

GENES
Volume 8, Issue 12, Pages -

Publisher

MDPI
DOI: 10.3390/genes8120364

Keywords

cesarean section; microbiome; microbiota; microbial community; obesity

Funding

  1. Ministry of Education (Capes)
  2. FIPE-HCPA, UFRGS
  3. Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2017R1D1A1B03029911]

Ask authors/readers for more resources

Cesarean (C-section) delivery, recently shown to cause excess weight gain in mice, perturbs human neonatal gut microbiota development due to the lack of natural mother-to-newborn transfer of microbes. Neonates excrete first the in-utero intestinal content (referred to as meconium) hours after birth, followed by intestinal contents reflective of extra-uterine exposure (referred to as transition stool) 2 to 3 days after birth. It is not clear when the effect of C-section on the neonatal gut microbiota emerges. We examined bacterial DNA in carefully-collected meconium, and the subsequent transitional stool, from 59 neonates [13 born by scheduled C-section and 46 born by vaginal delivery] in a private hospital in Brazil. Bacterial DNA was extracted, and the V4 region of the 16S rRNA gene was sequenced using the Illumina MiSeq (San Diego, CA, USA) platform. We found evidence of bacterial DNA in the majority of meconium samples in our study. The bacterial DNA structure (i.e., beta diversity) of meconium differed significantly from that of the transitional stool microbiota. There was a significant reduction in bacterial alpha diversity (e.g., number of observed bacterial species) and change in bacterial composition (e.g., reduced Proteobacteria) in the transition from meconium to stool. However, changes in predicted microbiota metabolic function from meconium to transitional stool were only observed in vaginally-delivered neonates. Within sample comparisons showed that delivery mode was significantly associated with bacterial structure, composition and predicted microbiota metabolic function in transitional-stool samples, but not in meconium samples. Specifically, compared to vaginally delivered neonates, the transitional stool of C-section delivered neonates had lower proportions of the genera Bacteroides, Parabacteroides and Clostridium. These differences led to C-section neonates having lower predicted abundance of microbial genes related to metabolism of amino and nucleotide sugars, and higher abundance of genes related to fatty-acid metabolism, amino-acid degradation and xenobiotics biodegradation. In summary, microbiota diversity was reduced in the transition from meconium to stool, and the association of delivery mode with microbiota structure, composition and predicted metabolic function was not observed until the passing of the transitional stool after meconium.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Endocrinology & Metabolism

Mode of delivery, type of labor, and measures of adiposity from childhood to teenage: Project Viva

Noel T. Mueller, Mingyu Zhang, Sheryl L. Rifas-Shiman, Emily Oken, Marie-France Hivert, Jorge Chavarro

Summary: Cesarean delivery is associated with higher childhood BMI-z, but this association is not significant when cesarean delivery is preceded by spontaneous labor.

INTERNATIONAL JOURNAL OF OBESITY (2021)

Article Endocrinology & Metabolism

Metformin Affects Gut Microbiome Composition and Function and Circulating Short-Chain Fatty Acids: A Randomized Trial

Noel T. Mueller, Moira K. Differding, Mingyu Zhang, Nisa M. Maruthur, Stephen P. Juraschek, Edgar R. Miller, Lawrence J. Appel, Hsin-Chieh Yeh

Summary: The study found that metformin treatment significantly altered gut microbiota composition at both 6 months and 12 months, while behavioral weight loss did not have the same effect. Additionally, both metformin and behavioral weight loss changed circulating SCFAs at 6 months, with an increase in acetate correlating with lower fasting insulin levels. Further research is needed to explore whether the gut microbiome mediates or modifies the health effects of metformin.

DIABETES CARE (2021)

Article Endocrinology & Metabolism

Effects of Behavioral Weight Loss and Metformin on IGFs in Cancer Survivors: A Randomized Trial

Hsin-Chieh Yeh, Nisa M. Maruthur, Nae-Yuh Wang, Gerald J. Jerome, Arlene T. Dalcin, Eva Tseng, Karen White, Edgar R. Miller, Stephen P. Juraschek, Noel T. Mueller, Jeanne Charleston, Nowella Durkin, Ahmed Hassoon, Dina G. Lansey, Norma F. Kanarek, Michael A. Carducci, Lawrence J. Appel

Summary: This study found that metformin may have a short-term effect on reducing IGF-1 levels in cancer survivors with obesity, but this effect diminishes over time.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2021)

Article Endocrinology & Metabolism

A behavioral weight-loss intervention, but not metformin, decreases a marker of gut barrier permeability: results from the SPIRIT randomized trial

Curtis Tilves, Hsin-Chieh Yeh, Nisa Maruthur, Stephen P. Juraschek, Edgar R. Miller, Lawrence J. Appel, Noel T. Mueller

Summary: This study aimed to investigate the effects of a behavioral weight-loss intervention and metformin treatment on plasma LBP. The results showed that only the behavioral weight-loss intervention reduced LBP compared to control, indicating that lifestyle weight-loss interventions that promote a DASH diet may effectively reduce gut barrier permeability to lipopolysaccharides.

INTERNATIONAL JOURNAL OF OBESITY (2022)

Article Cardiac & Cardiovascular Systems

Increases in Circulating and Fecal Butyrate are Associated With Reduced Blood Pressure and Hypertension: Results From the SPIRIT Trial

Curtis Tilves, Hsin-Chieh Yeh, Nisa Maruthur, Stephen P. Juraschek, Edgar Miller, Karen White, Lawrence J. Appel, Noel T. Mueller

Summary: The levels of butyrate in both serum and feces are associated with lowered blood pressure. Butyrate may serve as a target for interventions aimed at reducing blood pressure.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2022)

Article Peripheral Vascular Disease

Metabolome-Wide Association Study of Cord Blood Metabolites With Blood Pressure in Childhood and Adolescence

Mingyu Zhang, Tammy M. Brady, Jessie P. Buckley, Lawrence J. Appel, Xiumei Hong, Guoying Wang, Liming Liang, Xiaobin Wang, Noel T. Mueller

Summary: This study found that alterations in cord blood metabolome during infancy may be associated with the early life origins of hypertension, particularly related to acylcarnitine and purine metabolism.

HYPERTENSION (2022)

Review Pharmacology & Pharmacy

Gene editing strategies to treat lysosomal disorders: The example of mucopolysaccharidoses

Flavia Nathiely Silveira Fachel, Lariane Francio, Edina Poletto, Roselena Silvestri Schuh, Helder Ferreira Teixeira, Roberto Giugliani, Guilherme Baldo, Ursula Matte

Summary: This article reviews the clinical and molecular characteristics of lysosomal storage disorders, with a focus on mucopolysaccharidoses, and discusses the use of gene editing techniques to ameliorate their symptoms. Early results of clinical trials suggest that gene therapy may have a significant impact on the future treatment of these diseases, although hurdles related to specific hard-to-reach organs still need to be overcome.

ADVANCED DRUG DELIVERY REVIEWS (2022)

Review Biochemistry & Molecular Biology

Diet-Related and Gut-Derived Metabolites and Health Outcomes: A Scoping Review

Yuanxi Jia, Xuhao Yang, Lisa M. Wilson, Noel T. Mueller, Cynthia L. Sears, Glenn J. Treisman, Karen A. Robinson

Summary: This scoping review mapped the available evidence on the health impact of gut microbiota-derived metabolites. The study identified several metabolites that are associated with hepatobiliary disorders, colorectal cancer, and other digestive disorders. More prospective studies and clinical trials are needed to further understand the associations between metabolites and diseases.

METABOLITES (2022)

Article Biology

Drug Repositioning Applied to Cardiovascular Disease in Mucopolysaccharidosis

Gerda Cristal Villalba Silva, Thiago Steindorff, Roselena Silvestri Schuh, Natalia Cardoso Flores, Ursula Matte

Summary: This study aimed to identify drugs for treating cardiovascular disease in MPS patients and provided good practices for repositioning analysis. The results suggest that pirfenidone and colchicine are promising drug candidates.

LIFE-BASEL (2022)

Article Public, Environmental & Occupational Health

Associations of early life phthalate exposures with adolescent lipid levels and insulin resistance: The HOME Study

Taylor M. Etzel, Jordan R. Kuiper, Xiaobin Wang, Noel T. Mueller, Antonia M. Calafat, Kim M. Cecil, Aimin Chen, Bruce P. Lanphear, Kimberly Yolton, Heidi J. Kalkwarf, Joseph M. Braun, Jessie P. Buckley

Summary: A prospective study found that early-life phthalate exposures may affect cardiometabolic outcomes during adolescence. The concentrations of nine phthalate metabolites in urine samples collected during pregnancy and childhood were associated with cardiometabolic biomarkers at age 12, with differences observed between males and females.

INTERNATIONAL JOURNAL OF HYGIENE AND ENVIRONMENTAL HEALTH (2023)

Article Multidisciplinary Sciences

CRISPR/Cas patents and health-related publications in South America

Lariane Francio, Martiela V. de Freitas, Ursula Matte

Summary: The study reviewed the research progress of CRISPR/Cas system in South America, focusing on health-related applications. A total of 668 articles and 225 patents were found, with 192 articles analyzed in detail. Most studies targeted cancer, neurological, and endocrine disorders, while patents focused on inborn errors of metabolism, ophthalmological, hematological, and immunological disorders. No clinical trials involving Latin American countries were found.

ANAIS DA ACADEMIA BRASILEIRA DE CIENCIAS (2023)

Article Public, Environmental & Occupational Health

Sales of COVID kit drugs and adverse drug reactions reported by the Brazilian Health Regulatory Agency

Marina Hentschke-Lopes, Mariana R. Botton, Pamella Borges, Martiela Freitas, Aline Castello Branco Mancuso, Ursula Matte

Summary: The off-label use of azithromycin, hydroxychloroquine, and ivermectin for COVID-19 treatment in Brazil without clinical or scientific evidence has been associated with increased adverse drug reactions (ADR). This study examined the correlation between the sales of these drugs and the reported ADRs during the pandemic. The results show that the increased and indiscriminate use of the COVID kit is correlated to a higher occurrence of ADRs.

CADERNOS DE SAUDE PUBLICA (2022)

Review Biochemistry & Molecular Biology

Protection is not always a good thing: The immune system's impact on gene therapy

Martiela Vaz de Freitas, Lariane Francio, Laura Haleva, Ursula da Silveira Matte

Summary: This article provides an overview of current clinical trials for gene therapies and approved gene therapy products. It discusses the influence of the immune system on gene therapy effectiveness and strategies to overcome these challenges. By hiding the vector and transgene product from the immune system, as well as combining strategies such as patient screening and intelligent vector design, gene therapy has the potential to make a difference in the lives of patients with severe genetic diseases.

GENETICS AND MOLECULAR BIOLOGY (2022)

Article Biochemistry & Molecular Biology

Fantastic databases and where to find them: Web applications for researchers in a rush

Gerda Cristal Villalba, Ursula Matte

Summary: Public databases are essential for the development of multi-omics resources, providing a systematic way to store and access biological data. These user-friendly databases facilitate data mining and information search for healthcare professionals.

GENETICS AND MOLECULAR BIOLOGY (2021)

Article Endocrinology & Metabolism

Cardiac pathology in mucopolysaccharidosis I mice: Losartan modifies ERK1/2 activation during cardiac remodeling

Esteban Alberto Gonzalez, Santiago Alonso Tobar Leitao, Douglas dos Santos Soares, Angela Maria Vicente Tavares, Roberto Giugliani, Guilherme Baldo, Ursula Matte

Summary: MPS I, caused by mutations in the IDUA gene, leads to heart complications in patients. Studies suggest that losartan and propranolol can improve cardiac function in MPS I mice, potentially serving as adjunctive treatment options.

JOURNAL OF INHERITED METABOLIC DISEASE (2021)

No Data Available